176 related articles for article (PubMed ID: 33797490)
1. Resolution of organ dysfunction as a predictor of long-term survival in necrotizing soft tissue infections: Analysis of the AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections trial and a retrospective claims database-linked chart study.
Brakenridge SC; Wilfret DA; Maislin G; Andrade KE; Walker V; May AK; Dankner WM; Bulger EM
J Trauma Acute Care Surg; 2021 Aug; 91(2):384-392. PubMed ID: 33797490
[TBL] [Abstract][Full Text] [Related]
2. Impact and Progression of Organ Dysfunction in Patients with Necrotizing Soft Tissue Infections: A Multicenter Study.
Bulger EM; May A; Bernard A; Cohn S; Evans DC; Henry S; Quick J; Kobayashi L; Foster K; Duane TM; Sawyer RG; Kellum JA; Maung A; Maislin G; Smith DD; Segalovich I; Dankner W; Shirvan A
Surg Infect (Larchmt); 2015 Dec; 16(6):694-701. PubMed ID: 26381131
[TBL] [Abstract][Full Text] [Related]
3. A Novel Immune Modulator for Patients With Necrotizing Soft Tissue Infections (NSTI): Results of a Multicenter, Phase 3 Randomized Controlled Trial of Reltecimod (AB 103).
Bulger EM; May AK; Robinson BRH; Evans DC; Henry S; Green JM; Toschlog E; Sperry JL; Fagenholz P; Martin ND; Dankner WM; Maislin G; Wilfret D; Bernard AC;
Ann Surg; 2020 Sep; 272(3):469-478. PubMed ID: 32657946
[TBL] [Abstract][Full Text] [Related]
4. Validation of a clinical trial composite endpoint for patients with necrotizing soft tissue infections.
Bulger EM; May A; Dankner W; Maislin G; Robinson B; Shirvan A
J Trauma Acute Care Surg; 2017 Oct; 83(4):622-627. PubMed ID: 28538644
[TBL] [Abstract][Full Text] [Related]
5. Interventions for necrotizing soft tissue infections in adults.
Hua C; Bosc R; Sbidian E; De Prost N; Hughes C; Jabre P; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2018 May; 5(5):CD011680. PubMed ID: 29851032
[TBL] [Abstract][Full Text] [Related]
6. A Novel Drug for Treatment of Necrotizing Soft-Tissue Infections: A Randomized Clinical Trial.
Bulger EM; Maier RV; Sperry J; Joshi M; Henry S; Moore FA; Moldawer LL; Demetriades D; Talving P; Schreiber M; Ham B; Cohen M; Opal S; Segalovich I; Maislin G; Kaempfer R; Shirvan A
JAMA Surg; 2014 Jun; 149(6):528-36. PubMed ID: 24740134
[TBL] [Abstract][Full Text] [Related]
7. Predictors of mortality, limb loss, and discharge disposition at admission among patients with necrotizing skin and soft tissue infections.
Horn DL; Shen J; Roberts E; Wang TN; Li KS; O'Keefe GE; Cuschieri J; Bulger EM; Robinson BRH
J Trauma Acute Care Surg; 2020 Jul; 89(1):186-191. PubMed ID: 32102045
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with mortality in patients with extremity necrotizing soft-tissue infections: a single academic center experience.
Nagira K; Ogoshi T; Akahori K; Enokida S; Enokida M; Ueda T; Homma M; Nagashima H
Langenbecks Arch Surg; 2023 May; 408(1):189. PubMed ID: 37166568
[TBL] [Abstract][Full Text] [Related]
9. Complement Activation Is Associated With Mortality in Patients With Necrotizing Soft-Tissue Infections-A Prospective Observational Study.
Kristensen MK; Hansen MB; Madsen MB; Hansen CB; Pilely K; Hyldegaard O; Garred P
Front Immunol; 2020; 11():17. PubMed ID: 32082310
[No Abstract] [Full Text] [Related]
10. Transfer Is Associated with a Higher Mortality Rate in Necrotizing Soft Tissue Infections.
Khoury MK; Pickett ML; Cripps MW; Park SY; Nagaraj MB; Hranjec T; Hennessy SA
Surg Infect (Larchmt); 2020 Mar; 21(2):136-142. PubMed ID: 31448994
[No Abstract] [Full Text] [Related]
11. Sweet and Sour: Impact of Early Glycemic Control on Outcomes in Necrotizing Soft-Tissue Infections.
Beauchamp LC; Mostafavifar LG; Evans DC; Gerlach AT
Surg Infect (Larchmt); 2019; 20(4):305-310. PubMed ID: 30716012
[No Abstract] [Full Text] [Related]
12. Health-Related Quality of Life Is Decreased After Necrotizing Soft-Tissue Infections.
Suijker J; de Vries A; de Jong VM; Schepers T; Ponsen KJ; Halm JA
J Surg Res; 2020 Jan; 245():516-522. PubMed ID: 31450039
[TBL] [Abstract][Full Text] [Related]
13. Does Negative Pressure Wound Therapy Impact the Outcome for Patients With Necrotizing Soft Tissue Infection Infected With Anaerobic Bacteria?
Afzal H; Dawson E; Fonseca R; Canas M; Diaz L; Filippis A; Bochicchio KM; Bochicchio GV
Surg Infect (Larchmt); 2024 Apr; 25(3):179-184. PubMed ID: 38381953
[No Abstract] [Full Text] [Related]
14. Comorbidities Matter as Distressed Communities Index Fails to Predict Mortality in Necrotizing Soft Tissue Infection.
Villarreal ME; Jalilvand A; Schubauer K; Kellet W; DiDonato C; Roberts L; Helkin A; Scarlet S; Wisler J
Surg Infect (Larchmt); 2022 Nov; 23(9):801-808. PubMed ID: 36301537
[No Abstract] [Full Text] [Related]
15. Biomarkers of Necrotising Soft Tissue Infections Aspects of the Innate Immune Response.
Hansen MB
Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673381
[TBL] [Abstract][Full Text] [Related]
16. Association between adjunct clindamycin and in-hospital mortality in patients with necrotizing soft tissue infection due to group A Streptococcus: a nationwide cohort study.
Hamada S; Nakajima M; Kaszynski RH; Otaka S; Goto H; Matsui H; Fushimi K; Yamaguchi Y; Yasunaga H
Eur J Clin Microbiol Infect Dis; 2022 Feb; 41(2):263-270. PubMed ID: 34755257
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study.
Hua C; Sbidian E; Hemery F; Decousser JW; Bosc R; Amathieu R; Rahmouni A; Wolkenstein P; Valeyrie-Allanore L; Brun-Buisson C; de Prost N; Chosidow O
J Am Acad Dermatol; 2015 Dec; 73(6):1006-12.e8. PubMed ID: 26412163
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Patients with Necrotizing Soft Tissue Infections: A Propensity-Matched Analysis Using the National Inpatient Sample.
Collins CM; McCarty A; Jalilvand A; Strassels S; Schubauer K; Gonzalez-Gallo K; Young A; Wisler J
Surg Infect (Larchmt); 2022 Apr; 23(3):304-312. PubMed ID: 35196155
[No Abstract] [Full Text] [Related]
19. Clinical and Financial Outcomes of Necrotizing Soft-Tissue Infections in Safety-Net Hospitals.
Tran Z; Cho NY; Verma A; Sanaiha Y; Williamson C; Hadaya J; Gandjian M; Benharash P
J Surg Res; 2021 Nov; 267():124-131. PubMed ID: 34147002
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Antibiotic Duration after Surgical Debridement of Necrotizing Soft Tissue Infection.
Kenneally AM; Warriner Z; VanHoose JD; Ali D; McCleary EJ; Davenport DL; Parli SE
Surg Infect (Larchmt); 2022 May; 23(4):357-363. PubMed ID: 35262418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
